Tuesday, November 24, 2020

How will you feel when you have been given a Covid-19 shot?

Everyone will be keen to be given the shot and protect themselves and those around them as soon as possible.

Other News

Umno leader goes solo in frantic bid to shore up support for Anwar?

Source claims there has been lobbying by a senior politician ahead of a crucial budget vote.

Pemimpin Umno bergerak solo dapatkan sokongan untuk Anwar?

Sumber memberitahu seorang pemimpin kanan melobi menjelang hari pengundian belanjawan.

Bekas menteri bidas pengeluar sarung tangan Top Glove selepas lebih 1,000 pekerja dijangkiti Covid-19

Syed Saddiq Syed Abdul Rahman mengatakan syarikat itu perlu dikenakan ‘cukai durian runtuh’ kerana keuntungan luar biasa mereka.

Ex-minister slams Top Glove after over 1,000 workers down with Covid-19

Syed Saddiq Syed Abdul Rahman says a 'windfall tax' should be imposed on Top Glove due to its unusual profits.

1,884 kes baru Covid-19, Selangor tertinggi

Sebanyak 883 pesakit pulih.

People around the world are becoming excited at the news that vaccines which may stop the currently rampant Covid-19 virus will soon be available for mass inoculation programmes.

China has a vaccine it has been testing with several countries including Brazil.

Then the US and Germany announced that Pfizer has produced a vaccine that is 90% effective and will be widely available soon.

And now, as Russian pharma developers try to keep pace with Western drug makers in the race for a shot, Moscow announced on Wednesday that its Sputnik V vaccine is 92% effective at protecting people from Covid-19 in interim trial results.

Everyone will be keen to be given the shot and protect themselves and those around them as soon as possible.

But how does it feel when you have been injected with the vaccine?

Some volunteers who took part in Pfizer’s coronavirus vaccine trials say they were left feeling like they had a severe hangover, according to reports.

More than 43,500 people in six countries took part in Pfizer’s phase three trials. They were never told whether they had been injected with the vaccine or a placebo in the double-blind tests.

Some said they believe they were given the drug because of headaches, fever and muscle aches that were compared to getting the flu shot or recovering from a heavy night out, the Sun said.

Texan Glenn Deshields, 44, said his “severe hangover” symptoms soon cleared up, however, and he later took an antibody test that came back positive. He said he was “very excited” by news that the tests showed the vaccine was 90% effective.  “Thank God, it’s going to be over at some point,” he said.

Another volunteer who only gave her first name, Carrie, said she suffered a headache, fever and aches all over her body after her first shot – symptoms that were even more severe after the second one, Metro UK said. The 45-year-old from Missouri said taking part in the trials was her “civic duty”.

“There are so many people who have had Covid and suffered. The thought that we could do something to stop people from suffering from this, from losing family members, that we could get rid of it and get back to some sort of normal in our lives – that’s a driving factor for this for me,” she said. “I don’t want anyone else to be sick.”

Subscribe to our newsletter

To be updated with all the latest news and analyses.

Related Articles

AstraZeneca, Oxford say Covid vaccine shows 70% efficacy

The 70% average is lower compared with the efficacy of coronavirus vaccines trialled by rivals Pfizer/BioNTech and Moderna which have come in above 90%.

Pfizer, BioNTech say results show Covid-19 vaccine 95% effective

Pfizer and BioNTech say they are applying for US emergency approval 'within days'.

Poorer nations face vaccine wait as West locks down supply

Ethics aside, epidemiological data underscores the need for equitable vaccine distribution.

In new breakthrough, Moderna’s Covid-19 vaccine nearly 95% effective

Moderna plans to submit applications for emergency approval around the world within weeks.

Sanofi says its vaccine won’t need supercooling

Maintaining the 'ultra-cold chain' from factory to patients is expected to present an enormous logistical challenge.